← Back to Search

Other

Telehealth for Hepatitis C Treatment

N/A
Recruiting
Research Sponsored by Jens Rosenau
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
History of hepatitis C
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trialwill investigate if providing HCV treatment through a P&P office using telemedicine can help people get treatment without needing to travel to a specialist's office.

Who is the study for?
This trial is for individuals on probation or parole with a history of hepatitis C who will be supervised at the office for at least 5 months. They must have health insurance, be able to consent to the study, and have a life expectancy over one year. It's not open to those without active hepatitis C infection, pregnant or breastfeeding women, people co-infected with HIV/HBV, or those with severe liver cirrhosis.Check my eligibility
What is being tested?
The study tests if telehealth services in a probation and parole office can effectively link patients to hepatitis C care and treatment compared to previous methods. Participants receive consultations from HCV experts via telemedicine during regular appointments without extra travel.See study design
What are the potential side effects?
Since this trial focuses on service delivery rather than medication side effects are not detailed here. However, typical HCV treatments may include headaches, fatigue, nausea which would be monitored by healthcare providers.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had hepatitis C in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HCV treatment uptake rate of HCV RNA positive participants
Secondary outcome measures
Determine visit adherence
HCV treatment uptake rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants with Hepatitis CExperimental Treatment1 Intervention
Participants will be clients at the Lexington Probation and Parole office who are Hepatitic C positive.

Find a Location

Who is running the clinical trial?

AbbVieIndustry Sponsor
958 Previous Clinical Trials
502,234 Total Patients Enrolled
110 Trials studying Hepatitis C
32,679 Patients Enrolled for Hepatitis C
Jens RosenauLead Sponsor
1 Previous Clinical Trials
657 Total Patients Enrolled
1 Trials studying Hepatitis C
657 Patients Enrolled for Hepatitis C

Media Library

Telehealth in Parole/Probation Office (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05413785 — N/A
Hepatitis C Research Study Groups: Participants with Hepatitis C
Hepatitis C Clinical Trial 2023: Telehealth in Parole/Probation Office Highlights & Side Effects. Trial Name: NCT05413785 — N/A
Telehealth in Parole/Probation Office (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05413785 — N/A
Hepatitis C Patient Testimony for trial: Trial Name: NCT05413785 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current vacancies for individuals wishing to participate in this experiment?

"Affirmative, the information available on clinicaltrials.gov suggests that recruitment is ongoing for this trial which debuted on August 23rd 2022 and was last updated October 11th 2022. 150 participants are being sought at a single medical centre."

Answered by AI

How many participants are included in this experiment?

"Indeed, the information available on clinicaltrials.gov confirms that this research is looking to enroll 150 patients from a single location. This project was initiated and published on August 23rd 2022, with an update made October 11th of the same year."

Answered by AI

Is the eligibility criterion for this trial restricted to persons aged 55 or younger?

"This scientific trial is open to all individuals aged 18 or over and no older than 99."

Answered by AI

May I join the medical trial as a participant?

"This clinical trial is open to 150 adults with hepatitis c, aged 18-99. To qualify for the study, participants must be under probation or parole supervision for a minimum of five months; have existing documentation of their HCV status; access to health insurance coverage; demonstrate an understanding and agreement to the outlined protocol through written consent forms; and possess a prognosis indicating they will survive in excess of one year."

Answered by AI

Who else is applying?

What state do they live in?
Kentucky
What site did they apply to?
University of Kentucky
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I need money and I'm on parole (I reported to my PO today in Versailles!) and I have Hep C and am perfect for the job!
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Hepatitis C Treatment in Probation and Parole Office
Jens Rosenau 2022. "Hepatitis C Treatment in Probation and Parole Office". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05413785.
All > Hepatitis C
~14 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top